The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCATCo Regulatory News (CAT)

Share Price Information for CATCo (CAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.00
Bid: 13.00
Ask: 35.00
Change: 0.00 (0.00%)
Spread: 22.00 (169.231%)
Open: 24.00
High: 24.00
Low: 24.00
Prev. Close: 24.00
CAT Live PriceLast checked at -
CATCo Reinsurance Opportunities is an Investment Trust

To provide investors with significant capital returns and long-term distributions by making investments linked to catastrophe reinsurance risks via a variety of insurance-based investments.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

7 Dec 2017 07:00

RNS Number : 6233Y
CATCo Reinsurance Opps Fund Ltd
07 December 2017
 

CATCo Reinsurance Opportunities Fund Ltd.

Equity Issue

CATCo Reinsurance Opportunities Fund Ltd. (the "Company"), is pleased to announce that, in order to satisfy additional investor demand, 7,250,000 new C Shares have been issued under the Placing Programme at an issue price of $1.00, raising $7,250,000 (before costs and expenses). The net proceeds will be invested, in accordance with the Company's investment policy.

Application has been made for 7,250,000 C Shares to be admitted to trading on the Specialist Fund Segment of the London Stock Exchange. It is expected that Admission will become effective, and dealings will commence, at 8:00am (London time) on 12 December 2017. A prospectus relating to the issue is available on the Company's website at http://www.catcoreoppsfund.com.

Following Admission, the number of Ordinary Shares that the Company has in issue will be 391,666,430 and the number of C Shares that the Company has in issue will be 550,250,000. The C Shares carry the right to attend or vote at any general meeting of the Company in the same manner as the Ordinary Shares. Accordingly, the total number of voting rights in the Company will be 941,916,430 and the figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure Guidance and Transparency Rules.

For further information, please contact:

 

Judith Wynne, General Counsel

Mobile: +44 (0) 7986 205364

Telephone: +1 (441) 493 9005

Email: judith.wynne@markelcatco.com

 

Mark Way, Chief Operating Officer

Mobile: +1 (441) 504 9178

Telephone: +1 (441) 493 9001

Email: mark.way@markelcatco.com

 

Numis Securities Limited

Hugh Jonathan

Telephone: +44 (0) 20 7260 1000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEVQLFBDLFFFBZ
Date   Source Headline
16th May 200612:17 pmRNSEPT Disclosure
16th May 200611:42 amRNSEPT Disclosure
16th May 200610:45 amRNSRule 8.3- Cambridge Antibody
15th May 20062:56 pmRNSRule 8.3- Cambridge Antibody
15th May 20067:03 amRNSOffer for Cambridge Antibody
15th May 20067:03 amRNSStatement
13th Apr 200610:03 amRNSBlocklisting Interim Review
13th Apr 200610:00 amRNSBlocklisting Interim Review
13th Apr 200610:00 amRNSBlocklisting Interim Review
13th Apr 20069:52 amRNSBlocklisting Interim Review
7th Apr 20061:12 pmRNSHolding(s) in Company
6th Mar 200611:03 amRNS20-F filing
3rd Mar 200611:07 amRNSHolding(s) in Company
9th Feb 20065:23 pmRNSDirector/PDMR Shareholding
9th Feb 200610:49 amRNSDirector/PDMR Shareholding
6th Feb 20067:01 amRNS1st Quarter Results
3rd Feb 20063:30 pmRNSAGM Statement
3rd Feb 20061:00 pmRNSRe: Q1 2006 Statement
31st Jan 20069:22 amRNSNotice of Results
25th Jan 20063:01 pmRNSSales update
3rd Jan 200610:18 amRNSAdditional Listing
3rd Jan 20067:00 amRNSDirector/PDMR Shareholding
23rd Dec 200510:00 amRNSCAT Annual Report sent to FSA
20th Dec 20053:32 pmRNSHolding(s) in Company
20th Dec 20053:29 pmRNSDirector/PDMR Shareholding
5th Dec 200511:23 amRNSDirector/PDMR Shareholding
1st Dec 20053:36 pmRNSDirector/PDMR Shareholding
28th Nov 20054:11 pmRNSDirector/PDMR Shareholding
28th Nov 20057:02 amRNSFinal Results
25th Nov 20053:33 pmRNSDirector/PDMR Shareholding
1st Nov 20057:01 amRNSProduct Candidate Acquisition
27th Oct 20053:46 pmRNSNotice of Results
26th Oct 20057:01 amRNSCAT & ABBOTT AGREE ROYALTIES
12th Oct 20055:12 pmRNSHolding(s) in Company
5th Oct 20053:30 pmRNSResearch Update
30th Sep 20052:55 pmRNSBlocklisting Interim Review
30th Sep 20052:52 pmRNSBlocklisting Interim Review
30th Sep 20052:46 pmRNSBlocklisting Interim Review
23rd Sep 20054:34 pmRNSHolding(s) in Company
15th Sep 20054:19 pmRNSDirector/PDMR Shareholding
12th Sep 20057:01 amRNSDirectorate Change
12th Sep 20057:01 amRNS3rd Quarter Results
19th Aug 20059:39 amRNSHolding(s) in Company
18th Aug 200510:01 amRNSHolding(s) in Company
15th Aug 200510:17 amRNSNotice of Results
23rd Jun 20057:01 amRNSCAT-354 Clinical Update
1st Jun 20055:20 pmRNSHolding(s) in Company
20th May 20058:00 amRNSUpdate re Abbott
19th May 200512:31 pmRNSDirector Shareholding
16th May 20057:01 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.